Drug intelligence / Profile preview

Micetinoftalmina ointment

Development stage
Unknown
Lead developer
DÁVI
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Micetinoftalmina is an ophthalmic ointment containing chloramphenicol (10 mg/g), developed and marketed by the Portuguese pharmaceutical company DÁVI. Chloramphenicol is a broad-spectrum small molecule antibiotic that inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome, primarily exerting a bacteriostatic effect. It is indicated for the topical treatment of external eye infections and associated structures, including conjunctivitis, keratitis, blepharitis, and corneal ulcers, caused by susceptible microorganisms. The product is an approved, marketed medication in Portugal and is often used at night in combination with the eye drop formulation of the same name.

Brand names
Micetinoftalmina
Other names
Micetinoftalmina pomada oftálmica
02

Targets

PTC (50S ribosomal peptidyl transferase center)

Beyond the preview

Go deeper on Micetinoftalmina ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Micetinoftalmina ointment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call